SGLT2i Use Shows Lower Stroke Risk in T2D With Retinopathy Tags Stroke hBA1c SGLT-2 Inhibitor Read more about SGLT2i Use Shows Lower Stroke Risk in T2D With Retinopathy
CHG-BMI Index Outperforms Traditional Markers for DKD Risk Tags Diabetic Nephropathy Read more about CHG-BMI Index Outperforms Traditional Markers for DKD Risk
Higher FIB-4 Linked With Vascular Burden in T2DM Cohort Tags hBA1c Read more about Higher FIB-4 Linked With Vascular Burden in T2DM Cohort
Novel InMOI Index Flags Renal Impairment in New T2DM Cases Tags Diabetic Nephropathy Read more about Novel InMOI Index Flags Renal Impairment in New T2DM Cases
Bariatric Surgery vs Semaglutide Shows Mixed MASLD Outcomes in T2DM Tags GLP-1 agonists Read more about Bariatric Surgery vs Semaglutide Shows Mixed MASLD Outcomes in T2DM
Semaglutide Shows No Link to Lower Cirrhosis or HCC Risk Tags GLP-1 agonists Read more about Semaglutide Shows No Link to Lower Cirrhosis or HCC Risk
SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria
Central Obesity Associated With GDM and Postpartum Hypertension Risk Read more about Central Obesity Associated With GDM and Postpartum Hypertension Risk
Pregabalin Dose Matters for Pain Relief in Diabetic Neuropathy Tags Diabetic Neuropathy Read more about Pregabalin Dose Matters for Pain Relief in Diabetic Neuropathy
GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM Tags Sulphonylureas GLP-1 agonists DPP-4 inhibitors Thiazolidinediones Read more about GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM
